NCT03769831View on ClinicalTrials.gov

The PK/PD Study of SHR2285 Tablets in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 25, 2019

Primary Completion Date

July 22, 2019

Study Completion Date

July 22, 2019

Conditions
Thrombosis
Interventions
DRUG

SHR2285

Ascending dose oral adminstration

DRUG

Placebo

Ascending dose oral adminstration

Trial Locations (1)

100032

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT03769831 - The PK/PD Study of SHR2285 Tablets in Healthy Subjects | Biotech Hunter | Biotech Hunter